Abstract:The ideal food for new-borns is human breast milk, a mixture that provides a balanced combination of nutrients and bioactive components. Seeking to emulate maternal milk more effectively, this study assesses the impact of incorporating a multi-strain synbiotic and/or osteopontin (an active biopeptide) on the intestinal health of lactating pigs. Ninety-six weaned piglets were assigned to four dietary treatments in a 2x2 design. Treatments included: standard milk formula (CTR); CTR + probiotics (6.4x108 cfu/L Bifidobacterium longum subsp. infantis CECT 7210 and 1.1x108 cfu/L Lactobacillus rhamnosus NH001) + prebiotics (galacto-oligosaccharides 4.36 g/L and human-milk-oligosaccharide 0.54 g/L) (SYN); CTR + osteopontin (0.43 g/L) (OPN); and CTR + SYN + OPN (CON). Daily records including feed intake, body weight, and clinical signs, were maintained throughout the 15-day trial. Samples from blood, digestive content, and gut tissues were collected to determine serum TNF-α, intestinal fermentation (SCFA and ammonia), colonic microbiota (16S rRNA Illumina-MiSeq), histomorphology, and jejunal gene expression (Open-Array). No statistical differences were found in weight gain; however, animals supplemented with osteopontin exhibited higher feed intake. Regarding clinical signs, synbiotic supplementation led to shorter duration of diarrhoea episodes. The sequenced faecal microbiota revealed better control of potentially dysbiotic bacteria with CON diet at day 15. In colon compartment, an increase in SCFA concentration, a decrease in ammonia concentration, and a decrease in intraepithelial lymphocyte counts were observed in CON animals. Supplemented diets were also associated with modified jejunal gene expression. The synbiotic combination exhibited an upregulation of genes related to intestinal maturation (ALPI, SI) and nutrient transport (SLC13A1, SLC15A1, SLC5A1, SLC7A8), and downregulation of genes related to the response to pathogens (GBP1, TLR4) or inflammatory response (IDO, IL-1β, TGF-β1). Osteopontin promoted an upregulation of a digestive function gene (GCG). Correlational analysis between the microbiota population and various intestinal environmental factors (SCFA concentration, histology, and gene expression) proposes mechanisms of communication between the gut microbiota and the host. In summary, these results suggest an improvement in the colonic colonization process and a better modulation of the immune response when milk formula is supplemented with the tested synbiotic combined with osteopontin, benefiting from a synergistic effect.

Osteopontin in human milk and infant formula affects infant plasma osteopontin concentrations

An expert panel on the adequacy of safety data and physiological roles of dietary bovine osteopontin in infancy

Immunoregulation of bovine lactoferrin together with osteopontin promotes immune system development and maturation

Osteopontin in Bone Metabolism and Bone Diseases

Early-Life Supplementation of Bovine Milk Osteopontin Supports Neurodevelopment and Influences Exploratory Behavior

Longitudinal Changes of Lactopontin (milk Osteopontin) in Term and Preterm Human Milk

Effects of pasteurization on osteopontin concentrations in human breastmilk

Gastro-Intestinal Digested Bovine Milk Osteopontin Modulates Gut Barrier Biomarkers In Vitro

A Reversed-Phase HPLC Method for Determination of Osteopontin in Infant Formula

A Literature Review on Lactopontin and Its Roles in Early Life

Bovine milk osteopontin improved intestinal health of pregnant rats fed a high-fat diet through improving bile acid metabolism

The Bovine Lactoferrin-Osteopontin Complex Increases Proliferation of Human Intestinal Epithelial Cells by Activating the PI3K/Akt Signaling Pathway.

The impact of complexation or complex coacervation of lactoferrin and osteopontin on simulated infant gastrointestinal digestion, intestinal inflammation, and in vivo bone development

Supplementing infant milk formula with a multi-strain synbiotic and osteopontin enhances colonic microbial colonization and modifies jejunal gene expression in lactating piglets

Benefits of Lactoferrin, Osteopontin and Milk Fat Globule Membranes for Infants

Enrichment of low-abundance osteopontin in bovine milk via reciprocating free-flow isoelectric focusing

Increased serum osteopontin is a risk factor for osteoporosis in menopausal women

Longitudinal Changes in the Concentration of Major Human Milk Proteins in the First Six Months of Lactation and Their Effects on Infant Growth

Comparative evaluation of enriched formula milk powder with OPO and MFGM vs. breastfeeding and regular formula milk powder in full-term infants: a comprehensive study on gut microbiota, neurodevelopment, and growth

Epidermal growth factor and transforming growth factor-α in human milk of different lactation stages and different regions and their relationship with maternal diet.

Effects of recombinant osteopontin expressed in Escherichia coli on the recovery of the endometrial epidermal growth factor profile and fertility in repeat breeder dairy cows